Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Appendix Cancer and Pseudomyxoma Peritonei (ACPMP)

    Appendix Cancer and Pseudomyxoma Peritonei (ACPMP) supports researchers studying appendix cancer and PMP of appendiceal origin to improve disease understanding, diagnosis, and treatment.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Organization for Rare Disorders

    Due Dates: January 19, 2027, 11:59 pm PT (Initial application / Letter of Intent) | March 2027 (Full-proposal invitations) | June 2027 (Award announcements)

    Funding Amounts: Two awards of US $50,000 each

    Summary: Supports basic, clinical, and translational research to improve understanding, diagnosis, and treatment of appendix cancer and pseudomyxoma peritonei of appendiceal origin.

    Key Information: Funds cannot cover PI salary, overhead, or indirect costs.


    Description

    The National Organization for Rare Disorders (NORD), with funding from the Appendix Cancer/PMP Research Foundation, supports research on appendix cancer and pseudomyxoma peritonei (PMP) of appendiceal origin. The opportunity is part of NORD’s Rare Disease Research Grants Program and the foundation’s Catalyst Research Grants Program, supporting basic scientific, clinical, or translational studies.

    The program promotes research into the biology, epidemiology, genetics, pharmacology, immunobiology, or biochemistry of malignant epithelial neoplasms of the appendix. Eligible disease areas include appendiceal mucinous neoplasms, appendiceal adenocarcinomas—including signet ring cell and goblet cell adenocarcinoma—and appendiceal PMP. Priorities include innovative work with potential for diagnostic, therapeutic, or population-based advances, further external funding, additional preclinical studies, and clinical trials.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.